75. Deutsche Schacheinzelmeisterschaften
KGV : 0,17
BioPharm Asia, Inc. engages in the sale of medical products to drug stores, hospitals, neighborhood clinics, and other medicine retail outlets in the People?s Republic of China. Its products include approximately 300 prescription drugs; approximately 1,150 over the counter drugs comprising western medicines and traditional Chinese medicines for the treatment of common diseases; approximately 85 nutritional supplements consisting of healthcare supplements, vitamins, minerals, and dietary products; and various types of drinkable herbal remedies and packages of assorted herbs for making soup, which are used by consumers as health supplements. The company?s other products comprise personal care products, such as skin care, hair care, and beauty products; family care products, including portable medical devices for family use, birth control, and early pregnancy test products; convenience products, including soft drinks, packaged snacks, and other consumables; and cleaning agents and stationery, as well as seasonal and promotional items. As of December 31, 2009, it operated 360 retail drug stores. The company also involves in the cultivation of Chinese herbal medicines; production and sale of herbal and pharmaceutical products; and wholesale distribution of pharmaceutical and healthcare products. BioPharm Asia, Inc. is based in Tonghua County, the People?s Republic of China.
MFG
Chali
Optionen
gruss bigbäng
Optionen
NEW YORK, NY and TONGHUA, CHINA--(Marketwire -01/26/12)- BioPharm Asia, Inc. (Pinksheets: BFAR.PK - News) (the "Company") announced today that the company entered into an agreement to acquire Xiamen Tongji Hospital, a privately owned gynecology, obstetrics center based in Fujian province, China, for an undisclosed amount. Upon completion of the acquisition, BioPharm Asia will be responsible for the daily operation of the medical center. The deal is contingent upon approval from the Ministry of Commerce and is expected to close in the first quarter of 2012.
Tongji Hospital is a 300 patient bed hospital. Founded in 1993, with a well-echeloned staff structure, it offers a full range of gynecology services at a convenient geographic location. The acquisition of Xiamen Tongji Hospital accelerates BioPharm Asia's strategy, which aims to increase the accessibility of patient care for big cities with underserved, growing affluent middle class in China.
"BioPharm Asia continues to invest in the key emerging markets such as Xiamen where the combination of growing populations and increasing income are driving demand and expectations for better healthcare treatment," said Xiayang Hu, president of BioPharm Asia, Inc. "Our new acquisition further underscores our intention to serve the health needs of Xiamen patients through our specialized services and, increasingly, high-quality branded generic treatments that are locally produced to global standards."
"As China's economy has continuously made stride in recent history, a rising middle class with greater spending power demands higher quality of healthcare, but the truth is that they don't have many alternatives to choose. The company's new marketing plans should be able to make inroads with increasingly health-conscious urban customers."
MFG
Chali
Optionen
9. f 4 x e 5
gruss bigbäng
Optionen
grizz bigbäng
Optionen
Bin fix und fertig und leg mich mit ner Tasse Tee aufs Sofa...
Morgen hab ich frei, da können wir n bisschen weiterschachern...
Gruss und n schönen Abend wünscht dir bigbäng ;-)